Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of acquired immune deficiency syndromes"
DOI: 10.1097/qai.0000000000002250
Abstract: BACKGROUND Despite increased INSTI use, limited large-scale, real-life data exists on INSTI uptake and discontinuation. SETTING International multicohort collaboration. METHODS RESPOND participants starting dolutegravir (DTG), elvitegravir (EVG) or raltegravir (RAL) after 1/1/2012 were included. Predictors… read more here.
Keywords: uptake discontinuation; dtg evg; toxicity; evg ral ... See more keywords